AFFECTED FLOWOutflow (subsidised)
ANNOUNCED AS TEMPORARYNo
Other export incentive
On 1 February 2017, the Drug Regulatory Authority of Pakistan issued a Circular incentivizing Pharmaceutical firms and manufacturers with high export performance. The incentive is in the form of prioritizing registration of molecules, provided these drugs meet all prescribed requirements. One molecule will be granted priority for every USD 100,000 export of medicines during the year, subject to a maximum of 5 molecules per year.
⚑ Please report this page in case you detect an inaccuracy in its content.